Interaction of antituberculosis drugs with food

Authors

  • Nicolae BACINSCHI "Nicolae Testemițanu" State University of Medicine and Pharmacy
  • Ina GUTSU "Nicolae Testemițanu" State University of Medicine and Pharmacy
  • Tatiana RAKOVSKAIA "Nicolae Testemițanu" State University of Medicine and Pharmacy
  • Galina SPÎNOSU "Nicolae Testemițanu" State University of Medicine and Pharmacy

DOI:

https://doi.org/10.52692/1857-0011.2023.3-77.38

Keywords:

tuberculosis, antituberculosis drugs, interaction, food

Abstract

The peculiarities of the development and evolution of tuberculosis require a rich and varied diet to restore the nutritional status, reduce the incidence of gastrointestinal adverse reactions and increase adherence to treatment. Food can modify the pharmacokinetic parameters (Cmax, AUC, Tmax) and thus influence the effectiveness of antituberculosis drugs or contribute to the development of resistance. Rifampicin and isoniazid need to be taken on an empty stomach. Food does not significantly influence the pharmacokinetic parameters of pyrazinamide and ethambutol. Calcium-rich products will decrease the absorption of fluoroquinolones. Acidic drinks reduce the absorption and Cmax of cycloserine/terizidone and increase the absorption of paraaminosalicylic acid. Pharmacodynamic interaction can be observed when isoniazid is combined with products containing tyramine and histamine, with increased manifestations of adverse reactions.

Author Biographies

Nicolae BACINSCHI, "Nicolae Testemițanu" State University of Medicine and Pharmacy

Doctor of Medical Sciences, University Professor.; Department of Pharmacology and Clinical Pharmacology

Ina GUTSU, "Nicolae Testemițanu" State University of Medicine and Pharmacy

University Assistant.; Department of Pharmacology and Clinical Pharmacology

Tatiana RAKOVSKAIA, "Nicolae Testemițanu" State University of Medicine and Pharmacy

university assistant.; Department of Pharmacology and Clinical Pharmacology

Galina SPÎNOSU, "Nicolae Testemițanu" State University of Medicine and Pharmacy

university assistant.; Department of Pharmacology and Clinical Pharmacology

References

Arbex M.A., Varella Mde C., Siqueira H.R., Mello F.A. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs. J Bras Pneumol. 2010 Sep-Oct;36(5):626-40.

Arbex M.A., Varella Mde C., Siqueira H.R., Mello F.A. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second line drugs. J Bras Pneumol. 2010 Sep-Oct;36(5):641-56.

Banerjee S. Interactions between Common Foods and Drugs A Narrative Review. Asian Journal of Pharmaceutical Research. 2020 JulySeptember, 10(3): 188-194.

Bushra R., Aslam N., Khan A.Y. Food-Drug Interactions. Oman Medical Journal. 2011, 26(2): 77-83.

Denti P., Jeremiah K., Chigutsa E. et al. Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania. PLoS One. 2015 Oct 26;10(10):e0141002.

Kafle A., Mohapatra S.S., Sarma J., Reddy I. Fooddrug interaction: A review. The Pharma Innovation Journal 2018; 7(1): 114-118.

Kaneko T., Ishigatsubo Y. Isoniazid and food interactions: fish, cheese, and wine. Intern Med. 2005 Nov; 44(11): 1120-1..

Kumar A.K.H., Chandrasekaran V., Kumar A.K.et al. Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs. Indian J Med Res. 2017 Apr; 145(4): 530–535.

Lin M.Y., Lin S.J., Chan S.C., Lu Y.C. Impact of food and antiacids on the pharmaco-kinetics of antituberculosis drugs: systematic review and metaanalysis. Int J Tuberc Lung Dis. 2010; 14(7): 806818.

Peloquin C.A., Namdar R., Dodge A.A., Nix D.E. Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids. Int J Tuberc Lung Dis. 1999 Aug; 3(8): 703-10.

Saktiawati A.M. I. Sturkenboom M.G.G., Stienstra Y.et al. Impact of food on the pharmacokinetics of firstline anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial. Journal of Antimicrobial Chemotherapy, 2016; 71(3): 703-710.

Sturkenboom M.G.G., Märtson A.G., Svensson E.M. et al. Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs. Clin Pharmacokinet. 2021 Jun; 60(6): 685-710.

Wang J., Wang J., Du Y. et al. Effect of interval between food intake and drug administration at fasting condition on the plasma concentrations of first-line anti-tuberculosis drugs in Chinese population. Medicine (Baltimore). 2020 Oct 30; 99(44): e22258.

Ziani K., Negrei C., Ioniță-mîndrican C-B. et al. Drugfood interactions: the influence on the patient’s therapeutic plan. Farmacia. 2022; 70(5): 785-797.

Zhu M., Nix D.E., Adam R.D. et al. Pharmacokinetics of cycloserine under fasting conditions and with highfat meal, orange juice, and antacids. Pharmacotherapy. 2001 Aug; 21(8): 891-7.

Усов К. И. О проблеме влияния приема пищи на эффективность и переносимость противотуберкулезных препаратов. Сборник научных трудов Aнгарского государственного технического университета. 2022; 1: 238-242.

Published

2024-01-22

Issue

Section

Research Article

Categories